Trials / Completed
CompletedNCT01673399
Oxytocin Antagonist in Patients With Repeated Failure of Implantation
Oxytocin Antagonist in Patients With Repeated Failure of Implantation. A Prospective Randomized Placebo-controlled Double-blind Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- AZ Jan Palfijn Gent · Academic / Other
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
In this study the investigators compare the usual way of embryo transfer (without medication) with an embryo transfer while administering oxytocine antagonist. This to improve implantation and increase the pregnancy rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atosiban | Bolus atosiban 6.75mg + infusion atosiban 18mg/u during 3 hours. once administered starting 1 hour before embryotransfer. |
| DRUG | placebo |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2012-08-28
- Last updated
- 2021-02-02
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01673399. Inclusion in this directory is not an endorsement.